A Good Side to Nicotine?

Nicotine holds promise for treating diseases such as attention deficit hyperactivity disorder (ADHD), Parkinson's and Alzheimer's diseases, and schizophrenia. "Nicotine is a very simple molecule, and it affects receptors of many subtypes; therefore, the consequences, behavioral and biologic, are very broad," says Neil Grunberg, director of the Psychoendocrinology and Biochemistry Laboratory at the Uniformed Services University of the Health Sciences. Nicotinic receptors control the release of

Harvey Black
Jun 25, 2000

Nicotine holds promise for treating diseases such as attention deficit hyperactivity disorder (ADHD), Parkinson's and Alzheimer's diseases, and schizophrenia. "Nicotine is a very simple molecule, and it affects receptors of many subtypes; therefore, the consequences, behavioral and biologic, are very broad," says Neil Grunberg, director of the Psychoendocrinology and Biochemistry Laboratory at the Uniformed Services University of the Health Sciences.

Nicotinic receptors control the release of numerous neurotransmitters, including dopamine, acetylcholine, and norepinephrine, "which are important in the acute minute-to-minute running of the brain, your emotions, cognitive aspects of memory," says G. Kenneth Lloyd, a scientific consultant in Poway, Calif. Nicotinic receptors are also involved in controlling nerve growth factors, important for the health of neurons. "The nicotinic receptors seem to be pretty important and pervasive," he comments. There are six different types of nicotinic receptors in humans, says Michael Williams, vice president of neurological and urological...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?